Early prediction of response to tyrosine kinase inhibitors by quantification of EGFR mutations in plasma of NSCLC patients.

Marchetti, A; Palma Felicioni, J L; De Pas, T; Chiari, R; Del Grammastro, M; Filice, G; Ludovini, V; Brandes, A; Chella, A; Malorgio, F; Guglielmi, F; De Tursi, M; Santoro, A; Crinò, L; Buttitta, F